Speakers
Anna Hyde, Vice President of Advocacy and Access, Arthritis Foundation
Anna Hyde is the Vice President of Advocacy and Access at the Arthritis Foundation. She oversees both the federal and state legislative programs, in addition to grassroots engagement. Her focus is to raise the visibility of arthritis as a public health priority, build support for federal and state legislation that ensures access to affordable, high-quality health care, and enhance patient engagement in the policy-making process. Anna previously served as Senior Director of Advocacy and Access, managing the federal affairs portfolio and overseeing the state advocacy team.
Prior to joining the Arthritis Foundation in 2014, Anna worked as Senior Manager for Federal Affairs at the American Congress of Obstetricians and Gynecologists, where she managed a portfolio of issues including appropriations, physician workforce, and health IT. She began her health policy career as a Congressional Fellow for Energy and Commerce Committee members, where she drafted legislation and staffed Committee activities. Anna received a BA in History from Southern Methodist University, and taught junior high and high school history before moving to Washington D.C. in 2007 to pursue an MA in Political Science from American University.
Kayleigh Majercak, PhD, MS, Post-Doc Research Scientist, Clinical Outcomes Solutions
Kayleigh Majercak is currently a Post-doc Research Scientist at Clinical Outcomes Solutions. Her research interests include patient-centered outcomes research, patient-reported outcomes, patient experience data, and mixed-methods research. Kayleigh worked as a data analytics consultant at Humana, Inc using claims data. Her work focused on informing market leaders with population-level analytics to support Humana’s Bold Goal Communities’ initiative towards improving members’ health. At the University of Maryland Baltimore (UMB), her research and the focus of her PhD dissertation was co-developing a disease-agnostic survey template to fill the patient-centered evidence gaps in US value assessment, supported by a predoctoral fellowship with the National Health Council. Kayleigh earned her PhD in Pharmaceutical Health Services Research at UMB. She also holds a Master of Science degree in Pharmaceutical Evaluation and Policy from the University of Arkansas for Medical Sciences and a Bachelor of Science in Pharmaceutical Sciences degree from The University of Toledo.
Joey Mattingly, PharmD, MBA, PhD, Associate Professor and Vice Chair of Research, Department of Pharmacotherapy, University of Utah College of Pharmacy
Joey Mattingly, PharmD, MBA, PhD is Associate Professor and Vice Chair of Research for the Department of Pharmacotherapy at the University of Utah College of Pharmacy. His research portfolio primarily focuses on drug pricing policy, health economics, and patient-engagement where he has engaged policymakers at local, state, and federal levels. Dr. Mattingly served as temporary advisor to the Center of Medicare and Medicaid Services (CMS) to aid in the implementation of the new “Drug Price Negotiation Program” authorized under the Inflation Reduction Act and was named a Research Fellow for the National Association of Insurance Commissioners (NAIC). In January 2024, he was appointed to lead pharmacy benefits strategy for the University of Utah Health plan, representing over 30,000 employees at the University of Utah.